Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO)

ISSN： 1433-7398

Source： Brain Tumor Pathology, Vol.28, Iss.3, 2011-07, pp. : 185-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical characteristics and pathogenesis of cerebellar glioblastoma

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2383-2388

Spandidos Publications

Access to resources Recommend Favorite

Molecular pathogenesis of oligodendroglial tumors: Molecular pathogenesis of primary brain tumors. Guest Editors: Guido Reifenberger and V. Peter Collins

By Jeuken Judith W.M. Deimling Andreas Von Wesseling Pieter

Journal of Neuro-Oncology, Vol. 70, Iss. 2, 2004-11 ,pp. : 161-181

Springer Publishing Company

Access to resources Recommend Favorite

What is the most appropriate clinical target volume for glioblastoma?

By Lo Simon S Sahgal Arjun Slotman Ben J Mansur David B Khouri Anton Sloan Andrew E Machtay Mitchell Chang Eric L

CNS Oncology, Vol. 2, Iss. 5, 2013-09 ,pp. : 419-425

Future Medicine

Access to resources Recommend Favorite

Blood Alterations Preceding Clinical Manifestation of Glioblastoma

By Ilhan-Mutlu Aysegül Wagner Ludwig Wöhrer Adelheid Jungwirth Susanne Marosi Christine Fischer Peter Preusser Matthias

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 625-629

Informa Healthcare

Access to resources Recommend Favorite

Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1763-1767

Spandidos Publications

Access to resources Recommend Favorite